Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Search
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for ANGLE plc
Clear Filter
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
3
4
»
Date / Time
Source
Ticker
Company
Sector
Market Cap
Announcement
31May19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Positive Results from FDA Clinical Study
26Apr19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00
RNS-R
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix used in new cancer assessment technique
12Apr19 07:00
RNS-R
AGL:LON
ANGLE plc
Health
£31.9m
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
AACR 2019
11Mar19 07:00
RNS
LGEN:LON, AGL:LON
ANGLE plc, Legal & General Group Plc
Various
Various
Holding(s) in Company
07Mar19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Research into role of immune cells in cancer
31Jan19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Interim Results
29Jan19 07:00
RNS-R
AGL:LON
ANGLE plc
Health
£31.9m
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01
RNS
AGL:LON
ANGLE plc
Health
£31.9m
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Results
21Dec18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Issue of LTIP Options and Share Options
28Nov18 07:00
RNS-R
AGL:LON
ANGLE plc
Health
£31.9m
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
05Nov18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Acquisition of outstanding shares
01Nov18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Appointment of Dr Jan Groen as NED
30Oct18 16:21
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of AGM
29Oct18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Good Progress with FDA Studies
09Oct18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of AGM
25Jul18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Preliminary Results for year ended 30 April 2018
24Jul18 17:42
RNS
AGL:LON
ANGLE plc
Health
£31.9m
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of General Meeting
02Jul18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Preliminary Results
25Jun18 18:20
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Results of Fundraising
25Jun18 14:58
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Close of Accelerated Bookbuild
25Jun18 07:50
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Proposed Placing of New Ordinary Shares
04Jun18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Breakthrough Research with Parsortix
05Apr18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
First patient enrolled in FDA study
26Mar18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Research Update
06Feb18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Interim Results
10Jan18 10:16
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Results
08Jan18 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
12Dec17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Transfer of Lock-in Shares
08Dec17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
16Nov17 08:23
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Total Voting Rights and Covington Subscription
06Nov17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
06Nov17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
06Nov17 07:00
RNS
LGEN:LON, AGL:LON
ANGLE plc, Legal & General Group Plc
Various
Various
Holding(s) in Company
02Nov17 10:04
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
01Nov17 08:12
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of AGM
30Oct17 10:31
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of General Meeting
26Oct17 08:10
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Total Voting Rights
23Oct17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of AGM
12Oct17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Proposed further subscription for £2.8 million
09Oct17 07:02
RNS
AGL:LON
ANGLE plc
Health
£31.9m
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Potential new analytical protocol using Parsortix
05Oct17 11:46
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Results of Fundraising
05Oct17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Acquisition and Fundraising
13Sep17 17:36
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
13Sep17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Co-Marketing Partnership with QIAGEN
05Sep17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Change of Adviser
27Jul17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Preliminary Results
06Jul17 10:05
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Results
04Jul17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix breakthrough in prostate cancer
03May17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Business Update
04Apr17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
03Apr17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix enables analysis in head and neck cancer
30Mar17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Prostate Cancer Update
14Feb17 11:39
EQS
AGL:LON
ANGLE plc
Health
£31.9m
Edison issues outlook on Angle
26Jan17 07:01
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Interim Results
04Jan17 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Results
28Nov16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
ISSUE OF SHARE OPTIONS
24Nov16 14:48
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of GM
04Nov16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of GM
27Oct16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Director's share purchase
07Oct16 11:57
RNS
LGEN:LON, AGL:LON
ANGLE plc, Legal & General Group Plc
Various
Various
Holding(s) in Company
04Oct16 16:35
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Result of AGM
30Sep16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Research published in Clinical Chemistry
19Sep16 11:14
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Issue of Equity
09Sep16 16:12
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Annual Report and Accounts and Notice of AGM
27Jul16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Initiation of European ovarian cancer study
15Jul16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Results
15Jul16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix gaining traction at EACR Conference
01Jun16 15:04
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Holding(s) in Company
31May16 16:36
RNS
LGEN:LON, AGL:LON
ANGLE plc, Legal & General Group Plc
Various
Various
Holding(s) in Company
25May16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Placing
25May16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Cancer Research UK Contract
18Apr16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix potential in metastatic breast cancer
21Mar16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Parsortix potential for prostate cancer detection
09Mar16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
European patent grant for Parsortix
28Jan16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Interim Results
27Jan16 10:42
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Notice of Interim Results
25Jan16 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
UKE publishes evaluation of Parsortix
22Dec15 07:00
RNS
AGL:LON
ANGLE plc
Health
£31.9m
Completion of Geomerics Transaction
«
1
2
3
4
»
Date / Time
Source
Company
% Chg
31May19 07:00
RNS
ANGLE plc
-2.00%
Positive Results from FDA Clinical Study
26Apr19 07:00
RNS
ANGLE plc
-2.00%
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00
RNS-R
ANGLE plc
-2.00%
Parsortix used in new cancer assessment technique
12Apr19 07:00
RNS-R
ANGLE plc
-2.00%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00
RNS
ANGLE plc
-2.00%
AACR 2019
11Mar19 07:00
RNS
ANGLE plc, Legal & General Group Plc
-0.16%
Holding(s) in Company
07Mar19 07:00
RNS
ANGLE plc
-2.00%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00
RNS
ANGLE plc
-2.00%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00
RNS
ANGLE plc
-2.00%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00
RNS
ANGLE plc
-2.00%
Research into role of immune cells in cancer
31Jan19 07:00
RNS
ANGLE plc
-2.00%
Interim Results
29Jan19 07:00
RNS-R
ANGLE plc
-2.00%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01
RNS
ANGLE plc
-2.00%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00
RNS
ANGLE plc
-2.00%
Notice of Results
21Dec18 07:00
RNS
ANGLE plc
-2.00%
Issue of LTIP Options and Share Options
28Nov18 07:00
RNS-R
ANGLE plc
-2.00%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10
RNS
ANGLE plc
-2.00%
Holding(s) in Company
05Nov18 07:00
RNS
ANGLE plc
-2.00%
Acquisition of outstanding shares
01Nov18 07:00
RNS
ANGLE plc
-2.00%
Appointment of Dr Jan Groen as NED
30Oct18 16:21
RNS
ANGLE plc
-2.00%
Result of AGM
29Oct18 07:00
RNS
ANGLE plc
-2.00%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00
RNS
ANGLE plc
-2.00%
Good Progress with FDA Studies
09Oct18 07:00
RNS
ANGLE plc
-2.00%
Notice of AGM
25Jul18 07:00
RNS
ANGLE plc
-2.00%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42
RNS
ANGLE plc
-2.00%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34
RNS
ANGLE plc
-2.00%
Result of General Meeting
02Jul18 07:00
RNS
ANGLE plc
-2.00%
Notice of Preliminary Results
25Jun18 18:20
RNS
ANGLE plc
-2.00%
Results of Fundraising
25Jun18 14:58
RNS
ANGLE plc
-2.00%
Close of Accelerated Bookbuild
25Jun18 07:50
RNS
ANGLE plc
-2.00%
Proposed Placing of New Ordinary Shares
04Jun18 07:00
RNS
ANGLE plc
-2.00%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00
RNS
ANGLE plc
-2.00%
Breakthrough Research with Parsortix
05Apr18 07:00
RNS
ANGLE plc
-2.00%
First patient enrolled in FDA study
26Mar18 07:00
RNS
ANGLE plc
-2.00%
Research Update
06Feb18 07:00
RNS
ANGLE plc
-2.00%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00
RNS
ANGLE plc
-2.00%
Interim Results
10Jan18 10:16
RNS
ANGLE plc
-2.00%
Notice of Results
08Jan18 07:00
RNS
ANGLE plc
-2.00%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49
RNS
ANGLE plc
-2.00%
Holding(s) in Company
12Dec17 07:00
RNS
ANGLE plc
-2.00%
Transfer of Lock-in Shares
08Dec17 07:00
RNS
ANGLE plc
-2.00%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00
RNS
ANGLE plc
-2.00%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06
RNS
ANGLE plc
-2.00%
Holding(s) in Company
16Nov17 08:23
RNS
ANGLE plc
-2.00%
Total Voting Rights and Covington Subscription
06Nov17 07:00
RNS
ANGLE plc
-2.00%
Holding(s) in Company
06Nov17 07:00
RNS
ANGLE plc
-2.00%
Holding(s) in Company
06Nov17 07:00
RNS
ANGLE plc, Legal & General Group Plc
-0.16%
Holding(s) in Company
02Nov17 10:04
RNS
ANGLE plc
-2.00%
Holding(s) in Company
01Nov17 08:12
RNS
ANGLE plc
-2.00%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18
RNS
ANGLE plc
-2.00%
Result of AGM
30Oct17 10:31
RNS
ANGLE plc
-2.00%
Result of General Meeting
26Oct17 08:10
RNS
ANGLE plc
-2.00%
Total Voting Rights
23Oct17 07:00
RNS
ANGLE plc
-2.00%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05
RNS
ANGLE plc
-2.00%
Notice of AGM
12Oct17 07:00
RNS
ANGLE plc
-2.00%
Proposed further subscription for £2.8 million
09Oct17 07:02
RNS
ANGLE plc
-2.00%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01
RNS
ANGLE plc
-2.00%
Potential new analytical protocol using Parsortix
05Oct17 11:46
RNS
ANGLE plc
-2.00%
Results of Fundraising
05Oct17 07:00
RNS
ANGLE plc
-2.00%
Acquisition and Fundraising
13Sep17 17:36
RNS
ANGLE plc
-2.00%
Holding(s) in Company
13Sep17 07:00
RNS
ANGLE plc
-2.00%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00
RNS
ANGLE plc
-2.00%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00
RNS
ANGLE plc
-2.00%
Change of Adviser
27Jul17 07:00
RNS
ANGLE plc
-2.00%
Preliminary Results
06Jul17 10:05
RNS
ANGLE plc
-2.00%
Notice of Results
04Jul17 07:00
RNS
ANGLE plc
-2.00%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00
RNS
ANGLE plc
-2.00%
Parsortix breakthrough in prostate cancer
03May17 07:00
RNS
ANGLE plc
-2.00%
Business Update
04Apr17 07:00
RNS
ANGLE plc
-2.00%
Holding(s) in Company
03Apr17 07:00
RNS
ANGLE plc
-2.00%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00
RNS
ANGLE plc
-2.00%
Prostate Cancer Update
14Feb17 11:39
EQS
ANGLE plc
-2.00%
Edison issues outlook on Angle
26Jan17 07:01
RNS
ANGLE plc
-2.00%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00
RNS
ANGLE plc
-2.00%
Interim Results
04Jan17 07:00
RNS
ANGLE plc
-2.00%
Notice of Results
28Nov16 07:00
RNS
ANGLE plc
-2.00%
ISSUE OF SHARE OPTIONS
24Nov16 14:48
RNS
ANGLE plc
-2.00%
Result of GM
04Nov16 07:00
RNS
ANGLE plc
-2.00%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00
RNS
ANGLE plc
-2.00%
Notice of GM
27Oct16 07:00
RNS
ANGLE plc
-2.00%
Director's share purchase
07Oct16 11:57
RNS
ANGLE plc, Legal & General Group Plc
-0.16%
Holding(s) in Company
04Oct16 16:35
RNS
ANGLE plc
-2.00%
Result of AGM
30Sep16 07:00
RNS
ANGLE plc
-2.00%
Research published in Clinical Chemistry
19Sep16 11:14
RNS
ANGLE plc
-2.00%
Issue of Equity
09Sep16 16:12
RNS
ANGLE plc
-2.00%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00
RNS
ANGLE plc
-2.00%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00
RNS
ANGLE plc
-2.00%
Initiation of European ovarian cancer study
15Jul16 07:00
RNS
ANGLE plc
-2.00%
Notice of Results
15Jul16 07:00
RNS
ANGLE plc
-2.00%
Parsortix gaining traction at EACR Conference
01Jun16 15:04
RNS
ANGLE plc
-2.00%
Holding(s) in Company
31May16 16:36
RNS
ANGLE plc, Legal & General Group Plc
-0.16%
Holding(s) in Company
25May16 07:00
RNS
ANGLE plc
-2.00%
Placing
25May16 07:00
RNS
ANGLE plc
-2.00%
Cancer Research UK Contract
18Apr16 07:00
RNS
ANGLE plc
-2.00%
Parsortix potential in metastatic breast cancer
21Mar16 07:00
RNS
ANGLE plc
-2.00%
Parsortix potential for prostate cancer detection
09Mar16 07:00
RNS
ANGLE plc
-2.00%
European patent grant for Parsortix
28Jan16 07:00
RNS
ANGLE plc
-2.00%
Interim Results
27Jan16 10:42
RNS
ANGLE plc
-2.00%
Notice of Interim Results
25Jan16 07:00
RNS
ANGLE plc
-2.00%
UKE publishes evaluation of Parsortix
22Dec15 07:00
RNS
ANGLE plc
-2.00%
Completion of Geomerics Transaction
«
1
2
3
4
»
Date / Time
Company
% Chg
31May19 07:00
ANGLE plc
-2.00%
Positive Results from FDA Clinical Study
26Apr19 07:00
ANGLE plc
-2.00%
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00
ANGLE plc
-2.00%
Parsortix used in new cancer assessment technique
12Apr19 07:00
ANGLE plc
-2.00%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00
ANGLE plc
-2.00%
AACR 2019
11Mar19 07:00
AGL LSE,LGEN LSE
-0.16%
Holding(s) in Company
07Mar19 07:00
ANGLE plc
-2.00%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00
ANGLE plc
-2.00%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00
ANGLE plc
-2.00%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00
ANGLE plc
-2.00%
Research into role of immune cells in cancer
31Jan19 07:00
ANGLE plc
-2.00%
Interim Results
29Jan19 07:00
ANGLE plc
-2.00%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01
ANGLE plc
-2.00%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00
ANGLE plc
-2.00%
Notice of Results
21Dec18 07:00
ANGLE plc
-2.00%
Issue of LTIP Options and Share Options
28Nov18 07:00
ANGLE plc
-2.00%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10
ANGLE plc
-2.00%
Holding(s) in Company
05Nov18 07:00
ANGLE plc
-2.00%
Acquisition of outstanding shares
01Nov18 07:00
ANGLE plc
-2.00%
Appointment of Dr Jan Groen as NED
30Oct18 16:21
ANGLE plc
-2.00%
Result of AGM
29Oct18 07:00
ANGLE plc
-2.00%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00
ANGLE plc
-2.00%
Good Progress with FDA Studies
09Oct18 07:00
ANGLE plc
-2.00%
Notice of AGM
25Jul18 07:00
ANGLE plc
-2.00%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42
ANGLE plc
-2.00%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34
ANGLE plc
-2.00%
Result of General Meeting
02Jul18 07:00
ANGLE plc
-2.00%
Notice of Preliminary Results
25Jun18 18:20
ANGLE plc
-2.00%
Results of Fundraising
25Jun18 14:58
ANGLE plc
-2.00%
Close of Accelerated Bookbuild
25Jun18 07:50
ANGLE plc
-2.00%
Proposed Placing of New Ordinary Shares
04Jun18 07:00
ANGLE plc
-2.00%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00
ANGLE plc
-2.00%
Breakthrough Research with Parsortix
05Apr18 07:00
ANGLE plc
-2.00%
First patient enrolled in FDA study
26Mar18 07:00
ANGLE plc
-2.00%
Research Update
06Feb18 07:00
ANGLE plc
-2.00%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00
ANGLE plc
-2.00%
Interim Results
10Jan18 10:16
ANGLE plc
-2.00%
Notice of Results
08Jan18 07:00
ANGLE plc
-2.00%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49
ANGLE plc
-2.00%
Holding(s) in Company
12Dec17 07:00
ANGLE plc
-2.00%
Transfer of Lock-in Shares
08Dec17 07:00
ANGLE plc
-2.00%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00
ANGLE plc
-2.00%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06
ANGLE plc
-2.00%
Holding(s) in Company
16Nov17 08:23
ANGLE plc
-2.00%
Total Voting Rights and Covington Subscription
06Nov17 07:00
ANGLE plc
-2.00%
Holding(s) in Company
06Nov17 07:00
ANGLE plc
-2.00%
Holding(s) in Company
06Nov17 07:00
AGL LSE,LGEN LSE
-0.16%
Holding(s) in Company
02Nov17 10:04
ANGLE plc
-2.00%
Holding(s) in Company
01Nov17 08:12
ANGLE plc
-2.00%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18
ANGLE plc
-2.00%
Result of AGM
30Oct17 10:31
ANGLE plc
-2.00%
Result of General Meeting
26Oct17 08:10
ANGLE plc
-2.00%
Total Voting Rights
23Oct17 07:00
ANGLE plc
-2.00%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05
ANGLE plc
-2.00%
Notice of AGM
12Oct17 07:00
ANGLE plc
-2.00%
Proposed further subscription for £2.8 million
09Oct17 07:02
ANGLE plc
-2.00%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01
ANGLE plc
-2.00%
Potential new analytical protocol using Parsortix
05Oct17 11:46
ANGLE plc
-2.00%
Results of Fundraising
05Oct17 07:00
ANGLE plc
-2.00%
Acquisition and Fundraising
13Sep17 17:36
ANGLE plc
-2.00%
Holding(s) in Company
13Sep17 07:00
ANGLE plc
-2.00%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00
ANGLE plc
-2.00%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00
ANGLE plc
-2.00%
Change of Adviser
27Jul17 07:00
ANGLE plc
-2.00%
Preliminary Results
06Jul17 10:05
ANGLE plc
-2.00%
Notice of Results
04Jul17 07:00
ANGLE plc
-2.00%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00
ANGLE plc
-2.00%
Parsortix breakthrough in prostate cancer
03May17 07:00
ANGLE plc
-2.00%
Business Update
04Apr17 07:00
ANGLE plc
-2.00%
Holding(s) in Company
03Apr17 07:00
ANGLE plc
-2.00%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00
ANGLE plc
-2.00%
Prostate Cancer Update
14Feb17 11:39
ANGLE plc
-2.00%
Edison issues outlook on Angle
26Jan17 07:01
ANGLE plc
-2.00%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00
ANGLE plc
-2.00%
Interim Results
04Jan17 07:00
ANGLE plc
-2.00%
Notice of Results
28Nov16 07:00
ANGLE plc
-2.00%
ISSUE OF SHARE OPTIONS
24Nov16 14:48
ANGLE plc
-2.00%
Result of GM
04Nov16 07:00
ANGLE plc
-2.00%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00
ANGLE plc
-2.00%
Notice of GM
27Oct16 07:00
ANGLE plc
-2.00%
Director's share purchase
07Oct16 11:57
AGL LSE,LGEN LSE
-0.16%
Holding(s) in Company
04Oct16 16:35
ANGLE plc
-2.00%
Result of AGM
30Sep16 07:00
ANGLE plc
-2.00%
Research published in Clinical Chemistry
19Sep16 11:14
ANGLE plc
-2.00%
Issue of Equity
09Sep16 16:12
ANGLE plc
-2.00%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00
ANGLE plc
-2.00%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00
ANGLE plc
-2.00%
Initiation of European ovarian cancer study
15Jul16 07:00
ANGLE plc
-2.00%
Notice of Results
15Jul16 07:00
ANGLE plc
-2.00%
Parsortix gaining traction at EACR Conference
01Jun16 15:04
ANGLE plc
-2.00%
Holding(s) in Company
31May16 16:36
AGL LSE,LGEN LSE
-0.16%
Holding(s) in Company
25May16 07:00
ANGLE plc
-2.00%
Placing
25May16 07:00
ANGLE plc
-2.00%
Cancer Research UK Contract
18Apr16 07:00
ANGLE plc
-2.00%
Parsortix potential in metastatic breast cancer
21Mar16 07:00
ANGLE plc
-2.00%
Parsortix potential for prostate cancer detection
09Mar16 07:00
ANGLE plc
-2.00%
European patent grant for Parsortix
28Jan16 07:00
ANGLE plc
-2.00%
Interim Results
27Jan16 10:42
ANGLE plc
-2.00%
Notice of Interim Results
25Jan16 07:00
ANGLE plc
-2.00%
UKE publishes evaluation of Parsortix
22Dec15 07:00
ANGLE plc
-2.00%
Completion of Geomerics Transaction
«
1
2
3
4
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Actio Advisors
Align Research
Atrium Research
BlytheRay
BNP Paribas Exane - Sponsored Research
Brand Communications
BRR Media
Calvine Partners
Capital Access Group
Capital Markets Brokers
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
focusIR
Fundamental Research Corp
Galliano’s Latin Notes
goetzpartners securities Limited
H2 Radnor
Hardman & Co
Holland Advisors
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
NuWays
Paul Scott
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Resolve Research
SEAL Advisors Ltd
ShareSoc
Shore Capital
Small Cap Consumer Research LLC
StockBox
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
Turner Pope Investments
UK Investor Group
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cavendish
Couloir Capital
Dowgate Capital
First Berlin
First Sentinel
GSBR Research
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Clean Energy
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
Tennyson Securities
The Life Sciences Division
Turner Pope Investments
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
BNP Paribas Exane
BRR Media
Calvine Partners
Canaccord Genuity
Capital Access Group
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
First Berlin
First Sentinel
Five Minute Pitch TV
Fundamental Research Corp
Galliano’s Latin Notes
Goodbody
H2 Radnor
Hannam & Partners
Hardman & Co
Holland Advisors
Hybridan
Inbound Capital
Independent Investment Research
InterAxS Global
Investec Bank
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Clean Energy
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
NuWays
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
Small Cap Consumer Research LLC
SP Angel
Stanford Capital Partners
Stifel
StockBox
Tamesis Partners
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Contact
Sign Up
Sign In
Share: